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ABSTRACT 
Terpenes represent about half of known natural products, with terpene synthases 
catalyzing reactions to increase the complexity of substrates and generate cyclizations of 
the linear diphosphate substrates, therefore forming rings and stereocenters. With their 
diverse functionality, terpene synthases may be highly evolvable, with the ability to 
accept a wide range of non-natural compounds and with high product selectivity. Our 
hypothesis is that directed evolution of terpene synthases can be used to increase 
selectivity of the synthase on a specific substrate. In the first part of the work presented 
herein, three natural terpene synthases, Cop2, BcBOT2, and SSCG_02150, were tested 
for activity against the natural substrate and a non-natural substrate, called Surrogate 1, 
and the relative activities on both the natural and non-natural substrates were compared. 
In the second part of this work, a terpene synthase variant of BcBOT2 that has been 
evolved for thermostability, was used for directed evolution for increased activity and 
selectivity on the non-natural substrate referred to as Surrogate 2, shown below. 
Mutations for this evolution were introduced using random mutagenesis, with error prone 
polymerase chain reactions, and using site-specific saturation mutagenesis, in which an 
NNK library is designed with a specific active site amino acid targeted for mutation. The 
mutant enzymes were then screened and selected for enhancement of the desired 
functionality. Two neutral mutants, 19B7 W367F and 19B7 W118Q, were found to 
maintain activity on Surrogate 2, as measured by the screen. 
 
Surrogate 2 and Product. 
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C h a p t e r  1  
INTRODUCTION/BACKGROUND 
a. Introduction to Terpene Synthases 
Terpenes represent about half of known natural products, with terpene synthases having a 
variety of uses ranging from functions in primary metabolism, including as retinals and 
steroids, to functions in secondary metabolism, such as chemical attractants and repellents 
[19]. Amongst the most valuable terpenes are the pharmaceutically used products paclitaxel 
and artemisinin; the former being used for chemotherapy and the latter to treat malaria (Fig. 
1) [20]. Natural terpenes can often have highly desirable functionality, stemming from their 
remarkable selectivity in binding to receptors. This selectivity is due to their complexity in 
terms of containing chiral centers, dense functionality, and multi-cyclic aliphatic structures.  
 
Figure 1. Valuable potential pharmaceutical products Paclitaxel and Artemisinin. 
To make terpenes, nature starts with the five-carbon building blocks isopentyl diphosphate 
(IPP) and dimethylallyl diphosphate (DMAPP) [4]. These molecules are enzymatically 
joined to form longer chain diphosphates, which behave as substrates for the terpene 
synthases. The terpene synthases catalyze reactions that increase the complexity of the 
linear molecules, effecting cyclizations thereby forming rings and stereocenters (Fig. 2) 
[15]. From these cyclized structures, a large variety of compounds can be generated 
through further enzymatic conversions [11].  
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Furthermore, terpenes generally function as secondary metabolites, and terpene synthases 
produce a range of products [19]. In primary metabolic enzymes, natural selection has 
produced highly specific enzymes, with a catalytic landscape as seen in Figure 3. With 
specialized metabolic enzymes, such as terpene synthases, there exists a wider landscape of 
products that are produced with less specificity. With this diverse functionality, we believe 
that terpene synthases have the potential to be highly evolvable, with the ability to accept a 
wide range of non-natural compounds, and to be evolved to have high product selectivity 
[6], [17].  
 
Figure 2. Terpene Biosynthetic Pathway. 
The C15 isoprenoid diphosphate, farnesyl diphosphate (FPP), serves as the precursor for 
about 300 distinct terpene synthase products, called sesquiterpenes [11]. Further diversity 
of products can be created through biosynthetic derivatization in the form of P450-
mediated oxidations, enzymatic halogenations, and esterifications [18].  
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Figure 3. Specificity of catalytic landscapes of a primary metabolic enzyme vs. a 
specialized metabolic enzyme [19]. 
b. Previous Engineering Studies of Sesquiterpene Synthases 
Current literature has shown that terpene synthases can be engineered to use natural 
substrates to make new products, where the initial FPP substrate is capable of making a 
new product [21]. In work by Yoshikuni, rational design and random mutagenesis were 
combined to evolve a sesquiterpene synthase, (+)-δ-cadinene synthase, to function as a 
germacrene D-4-ol synthase. The focus was to create a variant that could shift from 
producing primarily (+)-δ-cadinene, which is the function of the natural terpene synthase, 
to produce germacrene D-4-ol, in order to demonstrate terpene synthase engineering (Fig. 
4). Twenty-one active variants were found, which were able to take the natural FPP 
substrate and generate products different from the parent enzymes [21].  
 
Figure 4. Comparison of the natural product, (+)-δ-cadinene, to the selected 
germacrene D-4-ol product. 
H
(+)-delta-cadinene germacrene D-4-ol
OH
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In order to identify active mutants, the group analyzed potential variants with GC-MS. 
This method was low throughput, and could only screen about 100 samples/day, so the 
group developed a selection for properly folded proteins to narrow down potentially 
improved mutants for screening. In this selection, variants were fused to chloramphenicol 
acetyltransferase (CAT), and proteins that exhibited proper folding were therefore soluble. 
Thus, recombinant E. coli containing this fusion construct grew in the presence of 
chloramphenicol and cells with improperly folded protein did not. This assay served to 
determine which variants should be analyzed by GC-MS, but was limited to a 
determination of enzyme solubility. The test was also not a good indicator of activity, 
which could have been valuable in predicting improved variants [21].  
The results attained by Yoshikuni’s screening determined that the variants with the most 
altered functionality were N403P and L405H. The parent terpene synthase produced (+)-δ-
cadinene with 98% selectivity, while in the final N403P and L405H variants germacrene 
D-4-ol was produced with 52%-53% selectivity. Identification of the products without an 
overlayer revealed that the L405H variant has a selectivity of 93% for the germacrene D-4-
ol product, a result that may be affected by evaporation of other products [21]. 
 
Figure 5. Homology structure of (+)-δ-cadinene (modeled on the crystal structure of 
5-epi-aristolochene) and structural annotation of mutations obtained from random 
mutagenesis [21]. 
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Identifying the ten most successful variants capable of producing germacrene D-4-ol, these 
corresponding mutations were mapped to a homology structure of (+)-δ-cadinene synthase, 
in order to determine the location of the active site. The mutations identified were centered 
primarily on the G-helix, shown in Figure 5 [21]. Overall, Yoshikuni’s work indicated the 
potential to evolve terpene synthases for product selectivity by creating mutations in the 
active site.  
 
Figure 6. Homology models of (A) Cop4, (B) Cop6, (C) Cop3, and (D) superimposed 
Cop4 open structure (yellow H-α1 loop) and Cop4 closed structure (blue H-α1 loop). 
Magenta indicates the open conformation; cyan indicates the closed conformation 
[12]. 
López-Gallego was interested in modifying natural terpene catalysts using site-directed 
mutagenesis, to vary the product profiles of the wild-type synthases. The research focused 
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on comparing conserved active sites of three terpene synthases: Cop3, Cop4, and Cop6. 
To identify the important qualities of the active sites, the models were compared at both the 
open (unbound) and closed (ligand –bound) conformations. Homology models of Cop3 and 
Cop4 were made using the crystal structure of aristolochene synthase, while Cop6 was 
modeled using the structure of trichodiene synthase (Fig. 6) [12].  
When superimposed, the three models (Fig. 6) indicated the H-α1 loop region was part of 
the active site, which in the closed conformation allowed the magnesium ion cluster, where 
the diphosphate binds, to move inwards. In this closed conformation, the three enzymes 
had active site cavities of the same volume. With Cop4 and Cop3 in the open conformation, 
the region was larger and more promiscuous, while the Cop6 in the open conformation had 
an active site that was smaller and more selective, at about half the volume. Looking at the 
product profiles for the three enzymes, the Cop6 was already very specific, while the Cop3 
and Cop4 had more range in the product profile. In performing site-directed mutagenesis, 
mutation sites within the H-α1 loop for the Cop6 sesquiterpene synthase had little effect on 
the product profile (Fig 7A). For the Cop4 and Cop3 enzymes, specific mutations enabled a 
greater diversity of products in some instances, and created more specialized variants of the 
sesquiterpene synthases in other cases (Fig. 7) [12].  
In addition to the site-specific mutations, the authors also attempted to switch the more 
promiscuous active site of Cop4 with the extremely selective active site of Cop6. The 
results of this switch indicated that the Cop6 and Cop6L4 (with the Cop4 acitve site) 
maintained essentially the same activity, while the Cop4 and Cop4L6 (with the Cop6 active 
site) exhibited completely different product selectivity (Fig. 8). Overall, this work 
suggested that identifying the H-α1 loop active site and targeting it for mutation was 
capable of generating product diversity of sesquiterpene synthases. 
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Figure 7. Influence of site-specific H-α1 loop mutations on product profiles of (A) 
Cop6, (B) Cop4, and (C) Cop3. Relative ratios of product can be seen in the charts, 
and compared to the wild-type charts given as Wt [12]. 
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Figure 8. Comparison of the influence of loop grafted Cop4 and Cop6 on the 
product profiles. Relative ratios of product can be seen in the charts, and with the 
original wild-type enzyme product profiles on the left and the loop grafted variants 
on the right [12]. 
Yoshikuni’s work was limited by the lack of a convenient screen to determine 
sesquiterpene synthase activity, which restricted the choice of terpene synthase possible to 
screen as well as the number of variants that could be easily tested and manipulated. López-
Gallego was restricted by site-directed mutagenesis, because they used GC-MS for 
characterization of product. With an improved screen to determine activity of sesquiterpene 
synthases, efficient directed evolution using random mutagenesis of many different terpene 
synthases could be performed, which could produce selective enzymes for a wide range of 
new terpene products.  
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c. Reactions of Analogs of FPP with Sesquiterpene Synthases 
Above it has been shown that terpene synthases can be engineered to follow new pathways 
and make new products. Work has also been done to look at the effects of changing the 
natural substrate, and thereby generate novel terpene compounds.  
In work by Cascón, analogous FPP substrates and two plant terpene synthases were used to 
make a library of new germacrene products [3]. The two plant sesquiterpene synthases used 
were germacrene A synthase (GAS), which converts FPP into germacrene A, and 
germacrene D synthase (GDS), which converts FPP into germacrene D. The original FPP 
was modified into FPP analogues, shown in Figure 9 [3].  
 
Figure 9. FPP (A) and five modified analog substrates (B-F). 
Reactions of the two synthases with the FPP analogues generated a library of germacrene 
analogues. The work has shown that the terpene synthase enzymes were capable of 
processing farnesyl diphosphate analogues into cyclized products [3].  
Observed success with the FPP analogues supports the conjecture that directed evolution of 
terpene synthases could be used to create enzymes capable of more effectively processing 
non-natural substrates. There are many opportunities to construct terpene synthases with 
altered functionality, and which could therefore access a whole new range of diverse and 
useful products (Fig. 10) [7], [14]. 
PPO
PPO
A.
B.
PPO
C.
F
F
PPO
PPO
D.
E.
PPO
F.
F
F
  
10 
 
Figure 10. Cyclization of FPP to give two representative products. 
d. Project Hypothesis 
The hypothesis is that directed evolution can be used to increase selectivity of a terpene 
synthase on a specific substrate. The specific aims of this research were to: 
1. Test three natural terpene synthases, Cop2, BcBOT2, and SSCG_02150, for activity 
against the natural substrate and a non-natural substrate, called Surrogate 1, and 
then to compare the relative activities on both the natural and non-natural 
substrates.  
2. Use directed evolution of a terpene synthase variant of BcBOT2 that has been 
evolved for thermostability to increase activity and selectivity on non-natural 
substrate Surrogate 2.  
 
Figure 11. Surrogate 2 and product. 
The reaction of Surrogate 2 with the terpene synthase BcBOT2 creates the product shown 
in Figure 11. Creating compounds with trans double bonds within a ring is difficult with 
synthetic chemistry, especially in small rings with high strain. This project could allow a 
faster and more efficient way to create new terpene synthases for the purpose of 
synthesizing new products. For the first time, terpene synthases could be evolved for non-
natural terpenes.  
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e. Approach 
i. AOX-Purpald Assay Screening  
In order to screen for activity, an assay was developed to test for the specific product 
formation. To apply this assay, surrogate FPP analog substrates with a methoxy group were 
created (Fig. 12).  
  
Figure 12. Structures of FPP (the natural substrate), Surrogate 1, and Surrogate 2. 
During reaction of the substrate and the terpene synthase, the cyclization would cause the 
release of methanol as a side product alongside the desired complex ring structure product. 
In previous studies, reaction of Surrogate 1 with the terpene synthase produced the 
products germacrene A and methanol, shown in Figure 13.  
 
Figure 13. Cyclization reaction of Surrogate 1. 
In the presence of alcohol oxygenase (AOX), the methanol was converted to formaldehyde. 
Ethylenediaminetetraacetic acid, EDTA, was used to kill the reaction between the lysate 
and substrate, and finally, purpald was added to cause a colorimetric response. In the AOX-
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Purpald assay, the formaldehyde reacted with purpald to produce a purple color 
corresponding to the concentration of product (Fig. 14) [8].  
 
Figure 14. Reaction of methanol with AOX-Purpald assay to produce colorimetric 
response. 
After the reaction with the purpald took place, some wells appeared purple while others 
appeared clear, and there was a gradient of different intensities of purple. These color 
changes were measured using a plate reader, recording the absorption at 550 nm. This color 
indicated which mutants were capable of producing methanol. Following the preliminary 
assays, mutants producing the purple color were re-screened using gas chromatography to 
screen for specific products.  
ii. Directed Evolution through Mutagenesis 
Directed evolution was chosen as a strategy to create variants for screening with the AOX-
Purpald assay. To develop terpene synthases with desired functions, the thermostable 
terpene synthase referred to as 19B7 was used as a starting point. This thermostable variant 
was a mutant of the original fungal terpene synthase BcBOT2, shown modeled on 
pentalenene synthase in Figure 15.  
This particular terpene synthase was used as a starting point for directed evolution because 
the terpene synthase BcBOT2 is one of the fastest natural terpene synthases available. In 
the model, the black region of the model indicates the magnesium ion binding region, 
which allows the diphosphate complexes to bind. The red region represents the areas that 
were mutated in order to produce the 19B7 thermostable structure. The increased 
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thermostability of the terpene synthase allows for more mutations to be introduced while 
maintaining activity [2], [5]. 
 
Figure 15. Proposed BcBOT2 structure modeled on pentalenene synthase; SWISS-
MODEL, Protein Structure Bioinformatic group at the Swiss Institute of 
Bioinformatics and the Biozentrum University of Basel. 
The primary goal of the research presented in this thesis was to use directed evolution to 
increase activity of the terpene synthase on a specific substrate. Mutations for this evolution 
were introduced using random mutagenesis, with error prone polymerase chain reactions, 
and using site-specific saturation mutagenesis, where an NNK library is designed with a 
specific active site amino acid targeted for mutation. The mutant enzymes were then 
screened and selected for enhancement of the desired functionality.  
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C h a p t e r  2  
MATERIALS AND METHODS 
a. Double Digestion 
In preparing a vector or insert from a given cryostock, cultures were grown in Luria Broth 
(LB) with Kanamycin overnight and then purified via the Qiagen Miniprep kit. Double 
digest reactions were set up for the vector and inserts in 50 µL samples. With 1 µL of XhoI 
New England Biolabs enzyme, 1 µL of NdeI New England Biolabs enzyme, 5 µL of New 
England Bio Labs Buffer 4, 0.5 µL of New England Biolabs BSA, and 1-2 µg of DNA, the 
remainder of the volume was filled up to 50 µL with autoclaved distilled water. The sample 
was then left at 37 °C for 1 hour, and purified through gel extraction, to be later used in 
ligation. 
b. Agarose Gel and Extraction 
A 1% agarose gel was poured (adding gel red) and left for about 20 minutes to solidify. 
The samples were run against a 1 KB ladder, with a ratio of 5:1 for dye to sample. The gel 
was run at about 100 V for about 20 minutes, and the resulting gel was analyzed under UV 
light. From preparatory gels, the gel was extracted using the procedure given by the 
Promega PCR clean-up system. 
c. Error Prone PCR 
The PCR mix was made of 1 µL of BcBOT2 forward primer (100 ng/µL for all primers), 1 
µL of BcBOT2 reverse primer, 1 µL of 2 mM dNTP’s, 5 µL of 2 mM MnCl2, 5 µL 10x 
Roche Taq Polymerase Buffer, 0.5 µL of 19B7 DNA template, and 0.5 µL of Roche DNA 
Taq polymerase, with the remainder of the volume filled up to 50 µL with autoclaved 
distilled water.  The program began with 98 °C for 3 minutes, followed by 30 cycles of 98 
°C for 0:30 / 62 °C for 0:30 --0.5 °C where the temperature was gradually lowered by 0.5 
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°C per cycle/ 72 °C for 1:45 ++0:05 where the extension time was gradually extended by 5 
seconds each cycle. With a final extension at 72 °C for 10 minutes, the program ended at 
10 °C for the remaining time. 
d. NNK library generation using overlap extension PCR 
The PCR program consisted of three rounds in order to combine the NNK library primers 
with the primers for the gene of interest. First there was the fragment PCR, where the PCR 
mix was made of 50 µL samples with 0.5 µL of template DNA (19B7), 1 µL of Phusion 
Polymerase, 10 µL of the 5x High Fidelity Phusion Buffer, 1 µL of dNTP’s, 1 µL of 
forward primer, 1 µL of reverse primer, and the rest with autoclave distilled water. [Note 
the enzymes used were generally acquired from New England Biolabs.] Two mixes were 
set up for each of the sets of primers, one with the specific forward primer and the BcBOT2 
reverse primer, the other with the specific reverse primer and the BcBOT2 forward primer. 
The fragment PCR program began with 98 °C for 2 minutes, followed by 35 cycles of 98 
°C for 0:30 / 55 °C to 75 °C (gradient PCR annealing temperatures) for 0:30 / 72 °C for 
1:30, and then a final extension at 72 °C for 10 minutes. The program ended at 10 °C for 
the remaining time, followed by preparation of the PCR assembly mix to combine the two 
products for each primer.  
Before the assembly step, a preliminary gel was run to see that there was product (as well 
as a gel extraction to purify the product). To set up the assembly PCR, the following 50 µL 
PCR mix was prepared, with 1 µL of template DNA from each of the fragment samples for 
the specific NNK, 1 µL of Phusion Polymerase, 10 µL of the 5x High Fidelity Phusion 
Buffer, 1 µL of dNTP’s, and the rest with autoclave distilled water. The mix was run in an 
assembly PCR program which again began with 98 °C for 2 minutes, but this time 
followed by 20 cycles of 98 °C for 0:30 / 55 °C to 75 °C (gradient PCR annealing 
temperatures) for 0:30 / 72 °C for 1:30, and a final extension at 72 °C for 10 minutes. The 
program ended at 10 °C for the remaining time. The final assembly PCR program was run 
after 1 µL of BcBOT2 forward primer and 1 µL of BcBOT2 reverse primer had been 
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added. The program was the same as the previous assembly PCR program, but with 25 
cycles instead of 20. 
Note that for the final libraries, an improved set of PCR conditions was used. In this 
procedure, the fragment assembly PCRmix was1µL of forward primer, 1µL of reverse 
primer, 1µL of dNTP’s, 10µL of New England Biolabs 5x High Fidelity Phusion Buffer, 
1µL of New England Biolabs Phusion Polymerase, 0.5µL of DNA (19B7) and finally 
35.5µL of autoclaved distilled water. The fragment PCR program again began with 98 °C 
but this time only for 0:30, followed by 30 cycles of 98 °C for 0:10 / 55 °C to 75 °C 
(gradient PCR annealing temperatures) for 0:20 / 72 °C for 0:20, and a final extension at 72 
°C for 10 minutes. The program ended at 10 °C for the remaining time. 
To set up the assembly PCR, the same 50 µL PCR mix was prepared as before. The mix 
was run in an assembly PCR program which began with 98 °C for 0:30, followed by 20 
cycles of 98 °C for 0:10 / 55 °C to 75 °C (gradient PCR annealing temperatures) for 0:20 / 
72 °C for 0:20, and a final extension at 72 °C for 10 minutes. The program ended at 10 °C 
for the remaining time. The final assembly PCR program was run after 1 µL of BcBOT2 
forward primer and 1 µL of BcBOT2 reverse primer had been added. The program was at 
98 °C for 2 minutes, followed by 25 cycles of 98 °C for 0:30 / 55 °C to 75 °C (gradient 
PCR annealing temperatures) for 0:30 / 72 °C for 1:45, and a final extension at 72 °C for 10 
minutes. The program ended at 10 °C for the remaining time. 
e. Ligation 
Ligation of an insert into a vector was typically done with 50 ng of the epPCR insert, 50 ng 
of vector, 2 µL of ligase buffer, 1 µL of New England Biolabs T4 DNA ligase enzyme, and 
the remainder of the volume filled up to 20 µL with autoclaved distilled water. The ligation 
was left overnight at 16 °C, and then transformed following the standard transformation 
procedure.  
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Note that for the final libraries, the ligation mix was modified for the NNK library. Due to 
inaccuracy of DNA concentration measurements, the mix was modified to have 10 µL of 
insert, 2.5 µL of vector, 1.5 µL of ligase buffer, 2 µL of New England Biolabs T4 DNA 
ligase enzyme, and no added water, to make a total volume of 15 µL. The ligation was still 
left overnight at 16 °C, and then transformed following the standard transformation 
procedure.  
f. Transformation 
From an existing ligation, transformation into LB agar plates with Kanamycin (50 mg/L) 
was typically done with 1 µL of the ligation added to 25 µL of thawed BL21 E. coli 
electrocompetent cells. The cells and DNA were transferred to an electroporation cuvette 
and pulsed at 2.5 kV. Immediately after, 950 µL of recovery media were added to the 
cuvette, and it was left to recover in a 37 °C shaker for 1 hr. From this mix, 200 µL were 
plated onto a large plate using bead shaking to spread the cells around the plate. The 
colonies were left in a 37 °C incubator overnight to grow. 
g. Making Libraries 
To make the library, colonies were picked from a large plate where error-prone PCR had 
been transformed into a large Luria Broth (LB) agar plate with Kanamycin. With sterilized 
toothpicks, individual colonies were picked into 96-well shallow plates with 300 µL of LB 
with Kanamycin in each well. These plates were left in a 37 °C shaker at 250 rpm and 80% 
humidity overnight. The next day 50 µL of these cultures were transferred to deep well 
plates with 800 µL of Terrific Broth (TB) with Kanamycin and left in a 37 °C shaker at 250 
rpm and 80% humidity for 4 hours, at which point the temperature was lowered to 25 °C 
for 30 minutes. The samples were then induced with 50 µL of 9 mM IPTG in TB and left 
in a 25 °C shaker at 250 rpm and no humidity overnight. The resulting cultures were spun 
down at 3,000 g at 4 °C for 10 minutes, after which the supernatant was poured out and the 
resulting pellets were frozen at -20 °C, ready for screening after freezing overnight.  
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h. Glycerol Stocks 
To make glycerol stocks of plates from the libraries, 120 µL of the material in the shallow 
wells was combined with 80 µL of 50% glycerol in microtiter plates, for a final 
concentration of 20% glycerol. Note that the plates were sterilized before use by spraying 
with ethanol and drying under the hood. These were sealed with USA Scientific Cold 
Storage Foil, and stored at -80 °C. 
i. Streaking Plates 
From an existing glycerol stock, a streaked out plate was made to isolate individual 
colonies, to allow these to grow into cultures to eventually attain purified DNA for 
sequencing or use as DNA template in PCR reactions. Streaking was done onto LB agar 
plates with Kanamycin, using sterilized toothpicks or disposable inoculating loops. The 
first toothpick or loop was used to transfer the glycerol stock to the plate using three 
strokes. Then a second clean toothpick or loop was used to streak three more lines that start 
from the strokes of the first toothpick or loop, to further separate the colonies out. A third 
clean toothpick or loop was used to stroke out three more lines, starting from the strokes of 
the second toothpick or loop, to help further distinguish the colonies. The plate was then 
left overnight in a 37 °C incubator overnight. 
j. Miniprep DNA  
Minipreping DNA started by picking a colony from a transformed or streaked out plate into 
4 mL of LB with Kanamycin, in a 15 mL round-bottomed culture tube. The culture was 
grown overnight in a 37 °C shaker, at a rate of 225 rpm or 250 rpm. The resulting cells 
were spun down for 10 minutes at 4,000g, and DNA was extracted using the protocols and 
materials of the QIAprep Spin Miniprep Kit by Qiagen. The resulting purified DNA was 
sent for sequencing, or used as DNA template for various PCR reactions.  
Note that sequencing samples were prepared by first streaking a cryostock, then growing 
cultures from the plate, and finally performing minipreps. 
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k. Stamping Plates 
Plates were stamped using a metal 96 well stamp, which wes sterilized with ethanol under a 
flame. The stamp was then placed in the desired 96-well cryostock plate, finally to be 
transferred to shallow 96-well plates with 300 µL LB with Kanamycin in each well. The 
remainder of the procedure followed exactly as with making the original libraries. 
l. Screening Substrates (with AOX Purpald Assay): Small Scale 
Screening for all libraries and substrates started by thawing deep well plates with cell 
pellets at room temperature for 30 minutes. Then, to lyse the cells, 300 µL of lysis buffer 
were added to each well, where the lysis mix for one plate was made with 35 mL of 
standard buffer (pH: 7.6, 50 mM 1,4-piperazinediethanesulfonic acid (PIPES), 10 mM 
magnesium chloride, 100 mM sodium chloride, 2 mM dithiothreitol) with 0.5 mg/mL 
lysozyme and 0.02 mg/mL DNase I. The plate was vortexed to ensure resuspension of the 
pellets, and then left in a 37 °C incubator for 1 hr. After incubation, the plate was spun 
down at 5,000 g at 4 °C for 15 minutes, separating the liquid lysate from the solid pellet at 
the bottom of the wells. Using a liquid-handling robot, 100 µL of lysate from each well was 
transferred to 96-well microtiter plates, where 100 µL of substrate in standard buffer was 
added. (Note that for the final, most recent library, this procedure was done by hand 
underneath the hood in order to prevent contamination.) The substrate was made so as to 
allow for a 0.5 mM final concentration. Typically, the original stock of substrate was at 10 
mM, so a 20x dilution into standard buffer was done immediately preceding addition of the 
substrate to the lysate. (This was done because the dithiothreitol in the standard buffer has 
the potential to degrade.) 
After the lysate and substrate were given 1-2 hours to react at 37 °C, 10 µL of alcohol 
oxygenase (50 µL of AOX stock solution dissolved in 950 µL of 0.1 M KPi, pH 8.0) was 
added to each well for 10 minutes at room temperature and 600 rpm, converting the side 
product methanol into formaldehyde. Next 16 µL of 0.5 M Ethylenediaminetetraacetic acid 
(EDTA) of pH 8.0 was added to each well for 1 minute at room temperature and 600rpm, 
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to stop the reaction. Finally, 50 µL of 0.16 M purpald in 2 M NaOH was added to each 
well. The plate was shaken at 600 rpm for 25 minutes at room temperature, after which a 
microtiter plate reader at 550nm and 10 flashes was used to record the absorbance of the 
wells. With the reaction of formaldehyde and purpald, a purple color appeared, typically 
indicative of high activity enzymes to be screened further.  
m. Screening Substrates (with Gas Chromatography): Medium Scale 
Screening done at the medium scale was done with 15 µL of 10mM substrate, 480 µL of 
standard buffer (with 10% betaine for certain reactions), and 5 µL of 2 µM enzyme. After 
these three components were mixed, 500 µL of hexane was added on top, carefully so as to 
not disturb the reaction. The samples were left to react at 30 °C, after which they were 
vortexed to stop the reaction, and centrifuged for 2 minutes at 10,000 g to separate the 
material into three layers – two liquid layers separated by a gel layer. The top layer of 
hexanes contained the product, which was extracted with a pipette and then run through a 
magnesium sulfate filter to remove excess water before running through a gas 
chromatography (GC) machine. Larger scale reactions were then performed, and analyzed 
using the gas chromatograph, which detected and distinguished the products.  
n. Screening Substrates (with Protein Purification): Large Scale 
Screening done at the large scale started with a 4 mL LB and Ampicillin pre-culture with a 
colony of the successful initial sample left overnight in a 37 °C incubator. The next day the 
sample was transferred to 500 mL of TB with ampicillin and metals mix, left shaking at 37 
°C and 225 rpm for about 4 hours until the OD600 reaches 1.8. Then the sample was put in a 
25 °C shaker for 30 min, and induced with 9 mM IPTG in TB for a final concentration of 
0.1 mM. The large culture flask was left shaking overnight. 
After the large culture grows overnight, it was poured into bottles and centrifuged at 5000 
rpm for 25 min at 4 °C. The supernatant was discarded and the remaining pellet is left at -
20 °C overnight. The next day the pellet was resuspended in 15 mL of Buffer A (pH: 7.6, 
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50 mM 2-amino-2-hydroxymethyl-propane-1,3-diol (TRIS), 5 mM magnesium chloride, 
300 mM sodium chloride, 5 mM dithiothreitol, and 10 mM imidazole) and sonicated by 
pulsing for 0.5 seconds then resting for 0.5 seconds for the course of 1 minute. This 
sonication program was repeated three times, inverting the tube in between each round. The 
sample was then centrifuged at 15,000rpm for 20 minutes at 4°C, after which it was run 
through a purification column. The purification column was first saturated with Buffer A, 
and then the protein (in Buffer A) was poured in and forced through the column as well. 
Then the Buffer A was run through the column again, followed by Buffer B  (pH: 7.6, 50 
mM TRIS, 5 mM magnesium chloride, 300 mM sodium chloride, 5 mM dithiothreitol, and 
500 mM imidazole) which eluted the purified protein in a clear but deep brown/amber 
color. This material was concentrated using 50mL Millipore concentration tubes, spinning 
four times at 3000g for 20min at 4°C, adding standard buffer to resuspend and concentrate. 
The final sample was frozen at -80°C. 
o. Compilation Plate 
A compilation plate was prepared using streaked plates or glycerol stocks, where individual 
cell samples or colonies were picked, using sterilized toothpicks or disposable inoculating 
loops, into a 96-well plate with 300 µL LB with kanamycin in each well. The resulting 
plate was grown with the remainder of the procedure following exactly as with making the 
original libraries.  
p. DpnI Treatment 
DpnI treatment was performed on the error prone PCR insert, or the fragment PCR insert. 
The addition of DpnI enzyme removed the excess template DNA. The initial minipreped 
template from E. coli was methylated. After PCR, only the original template retained 
methylation, so when the DpnI bound to the methylated DNA and degradeed it, the excess 
template decreases. In order to do this treatment, 1 µL of enzyme was added to the PCR 
sample and left at 37 °C for 1 hour.  
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q. Alkaline Phosphatase Treatment 
Alkaline phosphatase treatment was performed on the digested vector or plasmid DNA 
portion. When the vector was digested, then there was phosphate remaining on the ends of 
the DNA, which allowed the vector to close back upon itself. The addition of CIP (calf 
intestine alkaline phosphatase) removed the phosphate ends, and lessened the likelihood of 
the DNA binding to itself. This increased the likelihood of successful gene insertions 
during the ligation stage. In order to do this treatment, 1 µL of enzyme was added to the 
PCR sample and left at 37 °C for 1 hour.  
r. Random Mutagenesis 
A gene of interest was evolved through mutagenesis, where random mutations are 
introduced into the DNA to make a variety of different sequences and corresponding 
enzymes. When a gene of interest was selected then the gene was digested with two 
restriction endonucleases, as was a plasmid of DNA. The gene was then inserted into the 
vector (portion of the plasmid) through a ligation, and the resulting DNA was transformed 
into cells using electroporation. After plating, the cells grew small colonies with the gene in 
their DNA plasmid, and these colonies were grown into cultures from which this final 
DNA was extracted. With the gene of interest now in a plasmid, the DNA was used as a 
template to evolve and make a new library of enzymes. 
In directed evolution, the gene of interest in the vector was mutated through error prone 
PCR, making use of the natural error rate of Taq polymerase. The epPCR returned a mix of 
DNA with different mutations, and this DNA was transformed into electrocompetent cells 
to be plated to grow colonies with a variety of DNA sequences. These colonies were then 
grown as individual cultures, which were members of a library, where larger libraries had 
the benefit of expressing a greater range of mutations. Protein expression was induced, and 
the cells were frozen and kept at -20 °C. 
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Once the library was expressed, the cells were lysed and the enzyme was extracted to be 
screened for activity. Extracted lysate was combined with a substrate in standard buffer 
(see materials and methods), and left to react at 37°C. After the reaction has been given 
time to occur, a variety of preliminary assays were applied to determine which enzymes 
exhibit increased product formation. Larger scale reactions were repeated with the lysate, 
substrate, and buffer, which were then run through the gas chromatography machine to 
determine exactly which products were present.  
Note that the 19B7 library was generated by picking an overnight culture, which was then 
extracted using a miniprep procedure. Next, epPCR samples were prepared from the 19B7 
gene and subsequently treated with DpnI. Following gel extraction, the samples underwent 
double digestion using two endonucleases, XhoI and NdeI.  
The vector 03688 was also picked and grown in an overnight culture, from which DNA 
was extracted using the miniprep procedure. After miniprepping, the samples were digested 
with XhoI and NdeI, and treated with alkaline phosphatase or CIP (calf intestine 
phosphatase). Finally, a ligation was set up with the 19B7 epPCR into the digested vector 
03688. The ligation was left overnight at 16 °C, and then cleaned and concentrated using 
the Zymo Clean and Concentrate kit. This mix was then transformed into electrocompetent 
BL21 E. coli cells. These colonies were picked to make a library, which could then be 
screened. 
s. Site-Directed Mutagenesis 
With site-directed mutagenesis the process began with a fragment assembly PCR. The set 
up was for 50 µL samples with 0.5 µL of template DNA (19B7), 1 µL of Phusion 
Polymerase, 10 µL of the 5x High Fidelity Phusion Buffer, 1 µL of dNTP’s, 1 µL of 
forward primer, 1 µL of reverse primer, and the rest with autoclave distilled water. Two 
mixes were set up for each of the sets of primers, one with the specific forward primer and 
the BcBOT2 reverse primer, the other with the specific reverse primer and the BcBOT2 
forward primer. Then followed the fragment PCR program which was run as described in 
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the methods section. Before the assembly step, a preliminary gel was run to see that there 
was product, and the results were good, so this was followed with DpnI treatment to 
remove excess template. 
Following the same gel extraction procedure as before, the samples underwent double 
digestion with XhoI and NdeI. Ligation was performed overnight, followed by 
transformation of the cells onto LB Kanamycin plates. The cells were left to grow 
overnight, proving to have been successful. Therefore a library was picked. 
Using the library making procedure from before, a library of two plates was picked from 
each of the sets of primers, and screened for hits, also using the procedure for small scale 
screening described in the methods section. Note, the primers used for this procedure are 
given in Figure 16. 
Figure 16. Primers for the NNK sites for 19B7. 
  
NNK Site Forward Primer (5’->3’) Reverse Primer (5’->3’) 
W118NNK CTGGCGAGCATGNNKGCTCCG CTGGTGCATCCGGAGCMNNCATGCTCGCCA 
A119NNK GGCGAGCATGTGGNNKCCGGATGCAACAG 
CTGGTGCATCCGGMNNCCACATGC
TCGCC 
W133NNK GGTTATGATGCTGGATNNKAACCACTGGG 
CCCAGTGGTTMNNATCCAGCATCA
TAACC 
V137NNK GGAACCACTGGNNKTTTCTGTTTGATGACC 
GGTCATCAAACAGAAAMNNCCAG
TGGTTCC 
F138NNK CCACTGGGTANNKCTGTTTGATGACCAGTTC 
GAACTGGTCATCAAACAGMNNTAC
CCAGTGG 
W367NNK GGCAACCTGTATNNKAGCTTCCAGACCG 
CGGTCTGGAAGCTMNNATACAGGT
TGCC 
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C h a p t e r  3  
RESULTS AND DISCUSSION 
a. Comparison of FPP and Surrogate 1 Activity 
Data was gathered to compare the reactions that occur between a variety of natural terpene 
synthases with the natural substrate (FPP, farnesyl pyrophosphate), as well as Surrogate 1. 
The goal was to determine how the activity of various natural terpene synthases would be 
affected by the use of this non-natural Surrogate 1 substrate. Three wild-type terpene 
synthases were tested: Cop2, BcBOT2, and SSCG_02150. The primary products of these 
sesquiterpene synthases are shown in Figure 17 [10], [13], [16]. 
 
Figure 17. FPP cyclization products with (A) Cop2, (B) BcBOT2, and (C) 
SSCG_02150. 
Cop2 catalyzes the cyclization of FPP to germacrene A. The mechanism for the reaction 
can be seen in Figure 18. Cop2 performs a 1,10 cyclization to create germacrene A, which 
could serve as a valuable precursor for biofuels [1]. 
PPO
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H
OH
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SSCG_02150 H
PPO
A.
Farnesyl Pyrophosphate Germacrene A
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Figure 18. FPP cyclization mechanism in reaction with Cop2 [1]. 
BcBOT2 catalyzes the cyclization of FPP to presilphiperfolan-8β-ol [16]. The mechanism 
for the reaction can be seen in Figure 19. Presilphiperfolan-8β-ol is created by a 1,11 
cyclization [13]. 
  
Figure 19. FPP cyclization mechanism in reaction with BcBOT2 [13]. 
SSCG_02150 catalyzes the cyclization of FPP to epi-isozaene [9]. The mechanism for 
reaction can be seen in Figure 20. In order to form epi-isozizaene, SSCG_02150 performs a 
1,6 cyclization [13].  
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Figure 20. FPP cyclization mechanism in reaction with SSCG_02150 [13]. 
Taking purified protein of three terpene synthases, GC reactions were prepared with both 
the natural and the surrogate substrates. Data was gathered to compare behavior of FPP to 
Surrogate 1 with Cop2, BcBOT2, and SSCG_02150 as purified enzymes, for reaction times 
of 1 hour and over 24 hours (Fig. 21). The data represents the relative area-under-the-curve 
product formation, gathered from GC analysis.  
For all of the synthases, at 24 hours, there is about double the amount of product formed 
from FPP compared to product from Surrogate 1. In fact, FPP always shows greater 
product formation than S1. BcBOT2 appears to be the fastest catalyst, creating the most 
product material with both FPP and S1 after 1 hour, as was expected because BcBOT2 is 
one of the fastest terpene synthases according to literature values. With Cop2, we see 
slower product formation, but after 24 hours this terpene catalyst can produce as much 
product as BcBOT2, for both the FPP and S1 substrates. Finally, with SSCG_02150, we 
see that in 1 hour, very little product is formed. 
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Figure 21. Product formation from farnesyl pyrophosphate (FPP) BLUE and 
Surrogate 1 (S1) RED with Cop2, BcBOT2, and SSCG_02150. 
This data shows that BcBOT2 is the fastest functioning terpene synthase, showing that it is 
possible for a terpene synthase to perform a 1,11 cyclization efficiently. Cop2 is slower 
than BcBOT2, though both produce about the same amount of product after 24 hours. The 
mechanism for Cop2 involves a simpler cyclization than the mechanism for SSCG_02150, 
which was the slowest of the three sesquiterpene synthases and appeared poorly active at 1 
hour. In order for the reactions of the substrates with SSCG_02150 to undergo 1,6 
cyclization, the synthase must first undergo a rearrangement, which may slow down the 
overall product formation. SSCG_02150’s continued productivity over the 24-hour period 
showed that the terpene synthase stays active for a relatively long time, suggesting that it is 
stable at the conditions tested. This stability suggests that SSCG_02150 could be a good 
starting point for evolution, as stable enzymes are less likely to lose function during 
mutagenesis.  
For each of the terpene synthases, there has been analogous behavior between the natural 
substrate and the surrogate compound, with conversion of S1 at about half the rate of FPP. 
This consistent relationship between the two substrates was surprising, especially 
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considering the mechanistic differences between the enzymes. With BcBOT2 the 
cyclization includes a water-quenching termination step, and with SSCG_02150 and Cop2 
there is a carbocation elimination, both of which require different chemistry. Despite these 
differences, all of the enzymes were capable of S1 turnover, which suggest that many 
terpene synthases could be useful for converting non-natural substrates into products. 
Furthermore, it may be possible to incorporate methyl vinyl ether groups into non-natural 
substrates which terpene synthases can be active upon, such as with Surrogate 2. 
b. Round 1: Original Random Mutagenesis Library of 19B7 
The reaction of Surrogate 2 with 19B7 was performed. This reaction was analyzed by gas 
chromatography, which indicated a wide range of products (Fig. 22). Therefore, by 
pursuing random mutagenesis, there was the potential to be able to evolve selectivity for 
one of these specific products. 
 
Figure 22. Gas chromatography results of 19B7 with Surrogate 2. 
Within the Arnold laboratory, a library was generated through random mutagenesis of the 
thermostable parent terpene synthase variant 19B7. This mutant has a K85R mutation, and 
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a silent mutation at base 93. Re-stamping was done to grow a library of enzymes that were 
screened using Surrogate 2, and with the AOX-Purpald assay. No improved mutants were 
found. 
c. Round 2: New Random Mutagenesis Library of 19B7 
A new random mutagenesis library was created, using 19B7 as the parent enzyme. The 
library consisted of seventeen 96-well plates. From this new library, twelve of the plates 
were chosen at random for screening, with 24 potential hits combined to make a 
compilation plate, and four as potential hits. However, when re-screened, the compilation 
plate indicated the results were only parent. With an error rate of 2.1 base pair mutations 
per gene, and a coefficient of variation of 17%, this lack of improved mutations is as 
expected. The error rate is low for a mutagenesis library, indicating that more of our 
colonies than desired are likely to be parent. With a high coefficient of variation, we see 
that there is a large range in which the colorimetric assay will indicate variability, while 
still being parent. Therefore, false hits could appear to have higher absorbency in the 
screen, but in fact have no improvements. The lack of improved mutants may have 
stemmed from the fact that in random mutagenesis, large libraries of several thousand 
mutants should be screened in order to find improved mutants. 
d. Round 3: Directed Mutagenesis Library of 19B7 
The approach was shifted from random mutagenesis to site directed mutagenesis. Rather 
than using random mutations with libraries of twenty to thirty plates, specific amino acid 
residues were mutated (usually in the active site region) to create libraries of 1-2 plates. 
This allowed me to screen the library while conserving more of the Surrogate 2 substrate. 
In literature, active site saturation mutagenesis has been a successful method of approach to 
evolve enzymes for non-natural substrates. 
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Figure 23. Homology model indicating NNK sites, model based on pentalenene 
synthase. 
For the new libraries, six sets of primers with selected mutations in the active site were 
designed, which are referred to by the number of the amino acid to be mutated. The first 
letter indicates the amino acid to be changed, and the number is the amino acid location. 
These primers were designed to create an NNK library, where the amino acid in question 
was mutated to all other possible amino acids, and it was from these various primers that 
my new 19B7 libraries were prepared. The residues chosen for saturation mutagenesis were 
W118, A119, W133, V137, F138, and W367. These locations can be seen in the model in 
Figure 23. 
Work initially started with the three W libraries, the W118NNK, W133NNK, and 
W367NNK, with a fragment assembly PCR. The potential hits were combined into a 96 
well plate referred to as Comp 1 (Fig. 23), with each column corresponding to one variant. 
The entire procedure for the first three sets of primers was exactly repeated for the second 
three sets, being the A119NNK, the V137NNK, and the F138NNK.  
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Comp 1 AOX-Purpald Screen 
 
Blank Parent W367F W118V W118V Blank W118Q W133A W133A W367F Blank Blank 
A 0.1794 0.1455 0.1592 0.1395 0.1681 0.1309 0.1964 0.2163 0.1453 0.1535 0.1162 0.1134 
B 0.1186 0.1847 0.2143 0.2049 0.1229 0.1332 0.2042 0.1609 0.1508 0.2093 0.1202 0.1229 
C 0.1309 0.1724 0.1832 0.1719 0.1451 0.1291 0.2237 0.1709 0.1448 0.1886 0.1012 0.1166 
D 0.1704 0.261 0.2403 0.1449 0.1237 0.1146 0.1961 0.1638 0.1485 0.2213 0.1047 0.1202 
E 0.2788 0.2988 0.256 0.1946 0.2096 0.1567 0.2642 0.2007 0.147 0.2506 0.1405 0.1404 
F 0.1869 0.2856 0.2491 0.2477 0.2058 0.1797 0.2982 0.1708 0.1837 0.2144 0.148 0.1514 
G 0.1677 0.2719 0.2492 0.2443 0.1714 0.163 0.2875 0.1842 0.177 0.2116 0.1545 0.1751 
H 0.1782 0.2984 0.3166 0.1872 0.2273 0.1822 0.2993 0.2587 0.2268 0.2663 0.1728 0.1643 
Figure 24. Compilation plate from W118NNK, W133NNK, and W367NNK. Top 
three rows with DMSO, bottom five with normal screening. Boxes indicate potential 
hits from the NNK libraries from the AOX-Purpald screen. 
Note that the top three rows (A, B, and C) were screened with dimethyl sulfoxide, DMSO 
(Fig. 24). In the reaction between Surrogate 2 and the terpene synthase, the rate-limiting 
step is believed to be the release of product from the active site. The hypothesis was that 
treatment with DMSO could surround the product with DMSO in order to help the product 
release from the enzyme complex. However, the DMSO did not prove effective with 
Surrogate 2. 
There were three clones which displayed activity comparable to the parent. These clones 
proved to be two single mutants, 19B7 W367F and 19B7 W118Q. Mutating tryptophan 
(W) to phenylalanine (F) in 19B7 W367F is not expected to destroy the functionality of the 
enzyme, because it is switching from one aromatic amino acid to another aromatic amino 
acid. This mutation could in fact be helpful in increasing the size of the active site, because 
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phenylalanine is smaller than tryptophan. The other mutant, 19b7 W118Q, involves a 
change from an aromatic amino acid to a polar amino acid. This could be advantageous 
because having a more polar amino acid in the active site could help with releasing the 
product from the active site by allowing water into the active site to dislodge the product. 
In order to further characterize these mutants, both mutants were grown and expressed for 
protein purification. 19B7 W367F was successfully purified, and GC-scale reactions were 
performed with purified enzyme, to test for improved selectivity on the products of 
Surrogate 2. 
Having only neutral mutations with respect to activity on Surrogate 2, the NNK libraries 
did not deliver the hoped-for increase in product generation. This fact may be due to 
insufficient accuracy in modeling the amino acids that comprised the active site. The 
nearest homolog to BcBOT2 is only about 23% identical at the amino acid level, meaning 
that the active site model may be inaccurate, and the proposed NNK sites could be 
imperfectly selected. Using X-ray crystallography to obtain an accurate model of the 
enzyme would allow for better determination of the active site residues, and improved 
selection of NNK mutation sites.  
With directed evolution, it is important to consider the path of evolution that may be 
required to change the functionality of BcBOT2. In order to switch the activity of BcBOT2 
from FPP to S2, several mutations may be required. If the number of mutations required is 
high, then it may be necessary to implement an incremental approach to the evolution, 
where BcBOT2 is first evolved for high activity on Surrogate 1. When the enzyme is 
evolved to have a better Km for the vinyl methyl ether Surrogate 1, this enzyme could be 
easier to evolve for Surrogate 2. These intermediate variants may require neutral mutations 
in order to reach a significantly improved enzyme. 
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C h a p t e r  4  
CONCLUSIONS 
Three natural terpene synthases, Cop2, BcBOT2, and SSCG_02150, were tested for 
activity against the natural substrate and a non-natural substrate, where the relative 
activities on both the natural and non-natural substrates were compared. BcBOT2 proved 
to be the fastest, with Cop2 following next, and SSCG_02150 producing compatible 
product amounts after 24 hours. All of the natural terpene synthase enzymes were more 
active on FPP than the Surrogate 1 compound, but the activity between the two was 
highly correlated. 
With directed evolution for increased activity and selectivity on the unnatural substrate 
Surrogate 2, mutagenesis libraries have not been able to significantly improve enzyme 
activity. Initial random mutagenesis and site-specific saturation mutagenesis libraries 
produced two neutral mutants, 19B7 W367F and 19B7 W118Q, which were found by the 
screen to maintain activity on Surrogate 2. It is possible that the non-polar product of the 
Surrogate 2 reaction is difficult to separate from the enzyme, and therefore it may be 
difficult to evolve terpene synthases for this application. Furthermore, the site saturation 
mutagenesis towards the non-natural compound Surrogate 2 may have suffered from a 
lack of an accurate homology model, and the understanding of the active site 
configuration. Developing a better homology model by obtaining a successful crystal 
structure could improve the choice of amino acids for NNK libraries, and therefore 
produce mutations for all non-natural substrates of interest.  
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